Horror Stories Emerge After A Cursory Look At Chinese Corporate Leverage
Far less has been discussed about China’s corporate debt at the micro level. Back in October we were shocked when we looked at the inverse of corporate leverage, namely interest coverage within the heavily indebted commodity sector where we found that as of the end of 2014, just one half of Chinese companies could cover their annual interest expense, implying that according to a Macquarie analysis, some CNY2 trillion in debt was in danger of default.
This was over a year ago: since then both industry pricing and cash flow dynamics have deteriorated substantially and some estimate that more than three-quarters of leveraged commodity companies are dead zombies walking, suggesting a massive default wave is about to be unleashed.
And while we are keeping a close eye on this very troublesome development, last week the FT revealed something even more disturbing: Chinese corporate leverage, represented by the traditional debt/EBITDA ratio is, in some cases, absolutely ludicrous, especially among companies which in recent weeks have tried to mask their balance sheet devastation through global M&A activity, such as ChemChina’s recent record for a Chinese company $44 billion purchase of Syngenta, or Zoomlion’s $3.3 bid for US rival Terex last month.
In fact, as the otherwise demure FT notes, “so high are the debt levels at ChemChina and several other companies behind some of the country’s biggest overseas investments that financing for the deals would have been difficult or prohibitively expensive were it not for the backing of the Chinese state, analysts said.”
…click on the above link to read the rest of the article…
